A Phase 1 Escalating Single-Dose and Weekly Fixed-Dose Study of Cetuximab: Pharmacokinetic and Pharmacodynamic Rationale for Dosing

2007149 citationsJournal Article

Authors

This study provides a pharmacokinetic and pharmacodynamic rationale for the dosing of cetuximab.

Good health and well-being

Published in: Clinical Cancer Research

Volume 13, Issue 3, pp. 986-993

Field-Weighted Citation Impact: 6.60